Carnosic Acid Research Guide: Properties, Handling & Applications

Carnosic acid is a bioactive phenolic diterpene isolated primarily from rosemary (Salvia rosmarinus) and sage (Salvia officinalis) that has attracted considerable research interest for its potent antioxidant activity and ability to modulate cytoprotective signalling pathways including Nrf2.

CAS Number

3650-09-7

Molecular Formula

C₂₀H₂₈O₄

Molecular Weight

332.43 g/mol

Appearance

White to off-white crystalline powder

Primary Biological Activity

Antioxidant; Nrf2/ARE pathway activator

Recommended Storage

−20 °C, protected from light, under inert atmosphere

Common Solvents

DMSO, ethanol (limited aqueous solubility)

Chemical Identity and Physical Properties

Carnosic acid (CAS 3650-09-7; MW 332.43 g/mol; molecular formula C₂₀H₂₈O₄) is an abietane-type phenolic diterpene characterised by a tricyclic carbon skeleton bearing a catechol moiety at the C-11/C-12 positions and a carboxylic acid group at C-20. This ortho-dihydroxy arrangement is primarily responsible for its radical-scavenging capacity.

The compound appears as a white to off-white crystalline powder with a melting point typically reported in the range of 183–187 °C. It is practically insoluble in water but freely soluble in polar organic solvents such as DMSO and ethanol. Due to the oxidation-sensitive catechol ring, solutions and bulk material are susceptible to auto-oxidation; prolonged exposure to air converts carnosic acid to carnosol and other oxidation products.

Biological Activity and Research Applications

Carnosic acid is widely studied for its multi-target antioxidant and cytoprotective properties. Key research areas include:

• Nrf2/ARE activation: Carnosic acid acts as an electrophilic activator of the Keap1–Nrf2–ARE pathway, upregulating phase-II detoxification enzymes such as heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1). This mechanism underpins its use in oxidative-stress cell models.
• Neuroprotection: In vitro and in vivo studies have explored carnosic acid's ability to protect neuronal cells against oxidative damage, with relevance to models of neurodegenerative diseases.
• Anti-inflammatory activity: The compound has been reported to inhibit NF-κB signalling and reduce pro-inflammatory cytokine production in macrophage and other cell-based assays.
• Metabolic research: Emerging data suggest roles in adipogenesis regulation and glucose metabolism pathways, making it a subject of interest in metabolic disease research.
• Food science: As a major antioxidant constituent of rosemary extract (approved as food antioxidant E392 in the EU), carnosic acid serves as a reference standard in food chemistry and stability testing.

Solubility, Preparation and Working Solution Guidelines

Proper solution preparation is critical to reproducible results with carnosic acid.

1. Stock solution preparation: Dissolve carnosic acid in anhydrous DMSO or absolute ethanol to prepare a concentrated stock (typically 10–50 mM). Warm gently (37 °C water bath) and vortex to aid dissolution if necessary. Confirm complete dissolution visually before use.
2. Working dilutions: Dilute stock into aqueous cell culture media immediately before use to minimise oxidation. Final DMSO concentration in cell-based assays should not exceed 0.1 % (v/v) to avoid cytotoxicity artefacts. Use vehicle-matched controls in all experiments.
3. Aqueous formulations: If an aqueous formulation is required, consider using hydroxypropyl-β-cyclodextrin (HP-β-CD) as a solubilisation excipient; however, validate activity retention in your specific assay system.
4. Avoid repeated freeze–thaw cycles: Aliquot stock solutions into single-use volumes to prevent degradation.

Storage, Stability and Handling Precautions

Carnosic acid is sensitive to heat, light and oxidation. Adhering to the following precautions will protect compound integrity throughout its shelf life:

• Temperature: Store bulk material and aliquots at −20 °C. Short-term storage (up to 1 week) at 4 °C under inert gas is acceptable for frequently accessed vials.
• Light protection: Use amber vials or wrap containers in aluminium foil. UV exposure accelerates oxidative degradation.
• Inert atmosphere: Backfill storage vials with argon or nitrogen after each opening. This is especially important for small-volume aliquots where headspace-to-liquid ratio is high.
• Moisture control: Allow cold containers to equilibrate to room temperature before opening to prevent condensation on the powder, which can accelerate oxidation.
• Personal protective equipment: Wear appropriate PPE (gloves, lab coat, eye protection) when handling. Consult the Safety Data Sheet (SDS) for full hazard information before use.
• Quality check: Monitor the colour of solid material; yellowing or browning indicates oxidative degradation. Re-confirm purity by HPLC if material has been stored for extended periods or under sub-optimal conditions.

Experimental Design Considerations and Quality Control

To generate reliable, reproducible data with carnosic acid, researchers should consider the following experimental design factors:

• Dose–response characterisation: Establish a full dose–response curve in each assay system before interpreting single-concentration data. Carnosic acid can exhibit concentration-dependent dual effects (cytoprotective at low concentrations; potentially cytotoxic at high concentrations).
• Oxidation artefacts: Freshly prepared solutions should be used within 24 hours. If extended incubation is required, prepare solutions under low-oxygen conditions and protect from light throughout the experiment.
• Cell-type specificity: Nrf2 baseline expression varies across cell lines. Always verify pathway activation by measuring downstream markers (HO-1, NQO1 protein or mRNA) alongside viability readouts.
• Vehicle controls: Always include solvent (DMSO or ethanol) controls matched to the highest solvent concentration used in test wells.
• Positive controls: Sulforaphane or tert-butylhydroquinone (tBHQ) are commonly used Nrf2-activating positive controls and aid in inter-assay normalisation.
• Purity verification: For quantitative structure–activity studies, confirm purity ≥ 95 % by HPLC and identity by NMR or LC-MS before use. Request a Certificate of Analysis (CoA) from your supplier.

Frequently asked questions

What is the best solvent for dissolving carnosic acid for cell-based assays?

DMSO is the preferred solvent for preparing stock solutions of carnosic acid, as it offers good solubility and is compatible with most cell culture systems when diluted to ≤ 0.1 % (v/v) in the final assay volume. Absolute ethanol is a suitable alternative; aqueous solubility is too low for direct dissolution in buffer or media.

How should I store carnosic acid to prevent degradation?

Store carnosic acid as a solid at −20 °C in a tightly sealed, amber vial under an inert atmosphere (argon or nitrogen). Protect from light and moisture at all times. Dissolved stocks should be aliquoted to avoid repeated freeze–thaw cycles and used within 24 hours of preparation when possible.

Why does my carnosic acid solution turn yellow or brown during incubation?

Colour change is indicative of oxidative degradation of the catechol moiety in carnosic acid, producing carnosol and downstream quinone products. To minimise this, prepare solutions freshly, work under low-light conditions, limit dissolved oxygen by using degassed solvents, and avoid prolonged incubation at 37 °C in open vessels. Degraded solutions should not be used as they may contain bioactive oxidation by-products that confound results.

Is carnosic acid the same compound as carnosol?

No. Carnosic acid (CAS 3650-09-7) and carnosol (CAS 5957-80-2) are closely related but distinct diterpene phenols both found in rosemary. Carnosol is the lactone-containing oxidation product of carnosic acid. Both exhibit antioxidant and Nrf2-activating properties, but they differ in potency and pharmacokinetics; researchers should select the specific compound relevant to their study and use appropriate reference standards.

What positive control should I use when studying Nrf2 activation by carnosic acid?

Sulforaphane (an isothiocyanate from broccoli) and tert-butylhydroquinone (tBHQ) are both well-characterised Nrf2/ARE activators widely used as positive controls in oxidative-stress and cytoprotection assays. Including one of these controls alongside carnosic acid treatment allows cross-assay normalisation and confirms pathway responsiveness in the chosen cell model.

References

1. Aladdin Scientific product page: Carnosic acid, SKU C664235.
2. Masuda T, Inaba Y, Takeda Y. Antioxidant mechanism of carnosic acid: structural identification of two oxidation products. J Agric Food Chem. 2001;49(11):5560–5565.
3. Satoh T, Kosaka K, Itoh K, et al. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem. 2008;104(4):1116–1131.
4. European Food Safety Authority (EFSA). Re-evaluation of rosemary extracts (E 392) as a food additive. EFSA Journal. 2017;15(4):4649.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.